176 related articles for article (PubMed ID: 19772419)
21. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
23. Does extracapsular extension impact the prognosis of papillary thyroid microcarcinoma?
Chéreau N; Buffet C; Trésallet C; Tissier F; Golmard JL; Leenhardt L; Menegaux F
Ann Surg Oncol; 2014 May; 21(5):1659-64. PubMed ID: 24394985
[TBL] [Abstract][Full Text] [Related]
24. Papillary thyroid cancer: time course of recurrences during postsurgery surveillance.
Durante C; Montesano T; Torlontano M; Attard M; Monzani F; Tumino S; Costante G; Meringolo D; Bruno R; Trulli F; Massa M; Maniglia A; D'Apollo R; Giacomelli L; Ronga G; Filetti S;
J Clin Endocrinol Metab; 2013 Feb; 98(2):636-42. PubMed ID: 23293334
[TBL] [Abstract][Full Text] [Related]
25. [Long-term course in differentiated thyroid gland carcinoma].
Rösler H; Birrer A; Lüscher D; Kinser J
Schweiz Med Wochenschr; 1992 Nov; 122(48):1843-57. PubMed ID: 1462145
[TBL] [Abstract][Full Text] [Related]
26. Outcome after treatment of papillary thyroid microcarcinoma.
Appetecchia M; Scarcello G; Pucci E; Procaccini A
J Exp Clin Cancer Res; 2002 Jun; 21(2):159-64. PubMed ID: 12148571
[TBL] [Abstract][Full Text] [Related]
27. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
Grigsby PW; Reddy RM; Moley JF; Hall BL
Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
[TBL] [Abstract][Full Text] [Related]
28. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
29. [Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].
Lin YK; Sheng JM; Zhao WH; Wang WB; Yu XF; Teng LS; Ma ZM
Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):450-3. PubMed ID: 19595234
[TBL] [Abstract][Full Text] [Related]
30. Biologic considerations and operative strategy in papillary thyroid carcinoma: arguments against the routine performance of total thyroidectomy.
Cohn KH; Bäckdahl M; Forsslund G; Auer G; Zetterberg A; Lundell G; Granberg PO; Löwhagen T; Willems JS; Cady B
Surgery; 1984 Dec; 96(6):957-71. PubMed ID: 6505969
[TBL] [Abstract][Full Text] [Related]
31. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
[TBL] [Abstract][Full Text] [Related]
32. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation.
Vianello F; Mazzarotto R; Mian C; Lora O; Saladini G; Servodio O; Basso M; Pennelli G; Pelizzo MR; Sotti G
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):162-8. PubMed ID: 21411300
[TBL] [Abstract][Full Text] [Related]
35. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
36. Aggressiveness of therapy and prognosis of patients with Hürthle cell papillary thyroid carcinoma.
Besic N; Hocevar M; Zgajnar J; Petric R; Pilko G
Thyroid; 2006 Jan; 16(1):67-72. PubMed ID: 16487016
[TBL] [Abstract][Full Text] [Related]
37. [Surgical treatment of differentiated carcinoma of the thyroid. Retrospective study].
Gutiérrez JM; Fernández A; Eire PF; Mariño JM; Olivas JM; Alonso LA; Peramato PG; Pereira PL; Queizán A; Utrilla JG
Cir Pediatr; 1990 Apr; 3(2):73-5. PubMed ID: 2252852
[TBL] [Abstract][Full Text] [Related]
38. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
40. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
